Tags: immunotherapy

1/3/2017

By including independent viewpoints, STAT takes a more measured approach to coverage of brain cancer immunotherapy

1/3/2017

With no independent sources, TIME oversells brain cancer treatment

10/12/2016

Reuters’ ‘New day in lung cancer’ presents overly rosy picture of Keytruda

10/7/2016

Experimental immunotherapy for kids with leukemia gets balanced coverage by Washington Post

1 6/15/2016

Scientist’s quest to fight cancer: Captivating story from NPR overlooked limitations

5/24/2016

Except for presidential anecdote, NBC story on new melanoma drug was well-balanced

4/21/2016

Philly physician Q&A hits many key points on newer allergy treatments

11/2/2015

Coverage of virus-based cancer treatment skimps on cautions and key outcomes

9/10/2015

With focus on one patient, story manages to convey complexity of T-cell therapy for leukemia

4/22/2015

Story on new melanoma drug combo neglects to mention $250,000 price tag